Clinical Verification and Effect Evaluation of Chronic Disease Management Model for Patients with Lumbar Disc Herniation in Remission Period

本研究旨在验证和评价缓解期腰突患者慢病管理模式的临床效果。通过随机对照试验，纳入102例腰椎间盘突出症患者，分为对照组(传统治疗)和干预组(传统治疗联合慢病管理组)，对比两组患者的疼痛程度(VAS评分)、腰椎功能(JOA评分)及满意度。结果显示，干预组在治疗4周及随访3、6、12个月时，VAS评分显著低于对照组(均P This study aims to verify and evaluate the clinical effect of the chronic disease management model for patients with lumbar disc herniation in the remission period. Through a randomized controlled trial, 102 patients with lumbar disc herniation were enrolled and divided into a control group (conventional treatment) and an intervention group (conventional treatment combined with a chronic disease management group). The pain levels (VAS scores), lumbar function (JOA scores), and satisfaction of the two groups were compared. The results showed that at 4 weeks of treatment and during the 3-month, 6-month, and 12-month follow-ups, the VAS scores of the intervention group were significantly lower than those of the control group (all P < 0.05), the JOA scores of the intervention group were significantly higher than those of the control group (all P < 0.05), and the patient satisfaction in the intervention group reached 94.1%, which was significantly better than 78.4% in the control group. The conclusion indicates that the chronic disease management model can effectively relieve pain, improve function, and increase patient satisfaction, providing a scientific basis for the management of lumbar disc herniation in the community.